“Swiss Consensus Statement: Recommendations for Optimising Re-Treatment With MabThera® (rituximab) in Rheumatoid Arthritis”. Swiss Medical Weekly, vol. 140, no. 2728, July 2010, p. w13073, https://doi.org/10.4414/smw.2010.13073.